Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Disease, Chronic Obstructive

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Optimising the Propranolol Block Model

NCT00549120

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Safety, Blood Levels and Effects of GW642444

NCT00469040

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

A Study of GSK573719 in Healthy Japanese Male Subjects

NCT01013974

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Kagoshima, Japan

View Trial Details

Completed

A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

NCT00504439

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Phase I Study of GW642444M in Healthy Japanese Male Subjects

NCT00964249

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Fukuoka, Japan

View Trial Details

Completed

Phase I Study of GSK233705 in Healthy Japanese Male Subjects

NCT00964405

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Fukuoka, Japan

View Trial Details

Completed

A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.

NCT01266980

Conditions: Chronic Disease, Disease Attributes, Female Urogenital Diseases, +12 more
Locations: GSK Investigational Site Prague, Czechia

View Trial Details

Completed

An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers

NCT01449799

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00549679

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tampere, Finland

GSK Investigational Site Gauting, Bavaria, Germany

GSK Investigational Site Berlin, Germany

View all 15 locations

View Trial Details

Completed

A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects

NCT01691547

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details